Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12001202-0,08
KB101010110,00
PKN76,3176,33-1,90
Msft469,25469,98-0,33
Nokia4,6714,675-0,53
IBM276,18276,770,11
Mercedes-Benz Group AG52,2152,230,21
PFE24,3124,320,04
11.06.2025 13:50:00
Indexy online
AD Index online
select
AD Index online
 

  • 10.06.2025
RadNet (NASDAQ Cons)
Závěr k 10.6.2025 Změna (%) Změna (USD) Objem obchodů (ks)
59,29 0,37 0,22 553 458
Premarket11.06.2025 13:10:53
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 53,99 64,66 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.06.2025
Popis společnosti
Obecné informace
Název společnostiRadnet Inc
TickerRDNT
Kmenové akcie:Ordinary Shares
RICRDNT.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 8 546
Akcie v oběhu k 09.05.2025 75 030 098
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice1510 Cotner Ave
MěstoLOS ANGELES
PSČ90025
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon13 104 787 808
Fax13026365454

Business Summary: RadNet, Inc. is a national provider of fixed-site diagnostic imaging services in the United States. The Company has a network of over 401 owned and/or operated outpatient imaging centers. Its imaging centers provide physicians with capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. It also provides radiology information technology and artificial intelligence solutions.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Radnet Inc revenues increased 9% to $471.4M. Net loss increased from $2.8M to $37.9M. Revenues reflect Imaging Centers segment increase of 9% to $461.4M, Digital health segment increase of 18% to $10M. Higher net loss reflects Imaging Centers segment income decrease of 65% to $15.6M, Digital health segment loss increase from $605K to $3.1M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Medical & Diagnostic Laboratories
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSDiagnostic Imaging Centers
NAICSMedical Laboratories
NAICSCustom Computer Programming Services
NAICSComputing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
NAICS2007Diagnostic Imaging Centers
NAICS2007Medical Laboratories
NAICS1997Diagnostic Imaging Centers
NAICS1997Medical Laboratories
SICMedical Laboratories
SICMedical Laboratories
SICComputer Programming Services
SICData Processing And Preparation



  • Poslední aktualizace: 11.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerHoward Berger8001.01.1987
Chief Financial Officer, Executive Vice PresidentMark Stolper53
President and Chief Operating Officer- Eastern OperationsStephen Forthuber6401.01.2006
President and Chief Operating Officer - Western OperationsNorman Hames6906.08.2019
President and Chief Executive Officer - Digital HealthCornelis Wesdorp4801.10.202401.10.2024
Executive Vice President - Financial Planning and Analysis, Chief Administrative OfficerMital Patel3901.01.2016
Executive Vice President, Chief Information OfficerRanjan Jayanathan6901.01.2021
Executive Vice President, Chief Legal Officer, Corporate SecretaryDavid Katz6102.03.2020
Executive Vice President - Mergers and AcquisitionsMichael Murdock7001.01.2007
Chief Science Officer, DirectorA. Gregory Sorensen6308.08.202308.08.2023